Trials

Zacks Small Cap Analysis – PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Via Scientific Trials to Enhance Surgical Outcomes, Improve Remedy Efficacy, Reduce Facet Results – Model Slux

by
Zacks Small Cap Analysis – PYPD: Assessing & Advancing Lead Candidate D-PLEX₁₀₀, Via Scientific Trials to Enhance Surgical Outcomes, Improve Remedy Efficacy, Reduce Facet Results – Model Slux

By M. Marin NASDAQ:PYPD Revolutionary Drug Supply Platform (PLEX Know-how) PolyPid Ltd. (NASDAQ:PYPD) is a late medical stage biopharma firm centered on creating domestically administered, prolonged-release therapeutics utilizing its proprietary Polymer-Lipid Encapsulation matriX (PLEX) know-how, which permits the managed supply of medicines straight on the surgical web site over prolonged durations starting from days to … Read more

Zacks Small Cap Analysis – REVB Begins Trials with Good Money on Hand – Model Slux

by

By Brad Sorensen, CFA NASDAQ:REVB READ THE FULL REVBRESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences firm targeted on the event of immunologic-based therapies for the prevention and therapy of illness. Revelation has a number of product candidates in growth that we consider have promising potential and are primarily based on the biology of … Read more

x